Introduction
============

The neuronal nitric oxide (NO) synthase (nNOS) isoform is expressed by distinct populations of neocortical neurons (Karagiannis et al., [@B36]; Kubota et al., [@B41]). NO is well known to play crucial roles in the induction or regulation of neuronal plasticity (Garthwaite and Boulton, [@B26]) and is involved in various neuronal functions such as learning and memory (Rancillac and Crepel, [@B51]; Garthwaite, [@B25]), neuronal death (Dawson and Dawson, [@B11]; Kiss, [@B38]), and cerebral blood flow control (Iadecola et al., [@B34]; Moro et al., [@B47]; Rancillac et al., [@B52]). Despite these pleiotropic effects of prime importance, cortical nNOS-expressing neurons are still poorly understood. Characterizing these neurons is thus an important step toward understanding their physiological functions.

In the neocortex nitrergic neurons are mainly GABAergic (Valtschanoff et al., [@B61]) and are generally divided in type I and type II neurons according to the intensity of NADPH diaphorase activity and/or nNOS immunoreactivity (Yan et al., [@B73]; Yan and Garey, [@B72]; Judas et al., [@B35]; Smiley et al., [@B55]; Lee and Jeon, [@B43]). Type I cells usually exhibit large somata, are intensely stained and represent about 2% of total GABAergic interneurons in the rat primary sensorimotor cortex (Kubota et al., [@B40]). In rodents, they are found in all cortical layers (Oermann et al., [@B48]), although they are more frequently observed in infragranular layers (Vercelli et al., [@B62]; Wiencken and Casagrande, [@B67]; Garbossa et al., [@B24]; Lee and Jeon, [@B43]). Immunohistochemical studies indicate that type I cells frequently co-express neuropeptide Y (NPY) and somatostatin (SOM; Dawson et al., [@B10]; Kubota et al., [@B40]; Gonchar and Burkhalter, [@B29]; Estrada and Defelipe, [@B15]; Smiley et al., [@B55]).

Type II cells, for their part, are much smaller and weakly stained (Yan et al., [@B73]). First described in the primate and human cortex (Aoki et al., [@B1]; Hashikawa et al., [@B31]; Gabbott and Bacon, [@B21]; Yan et al., [@B73]), they were recently reported in rodents (Lee and Jeon, [@B43]). Because of the technical limitations in identifying type II neurons, they have largely been neglected and their neurochemical characteristics are not well studied. In addition, little information is available regarding the morphological and electrophysiological characteristics of type I and type II nNOS-expressing neurons (Kilduff et al., [@B37]).

In the present study, we characterized cortical nitrergic interneurons with immunohistochemical labeling of distinct chemical markers in GAD67:GFP knock-in mice (Tamamaki et al., [@B56]). Furthermore, a multiparametric analysis of neurons expressing nNOS mRNA was performed using whole-cell current-clamp recordings coupled to single-cell reverse transcription (scRT)-PCR in acute slices of mouse somatosensory barrel cortex. Unsupervised clustering revealed the presence of four major classes of nitrergic neurons whose properties correlated to type I and type II nNOS immunoreactivity. Finally, we assessed the embryonic origins of type I and type II interneurons by using immunohistochemistry on mouse lines co-expressing GFP/YFP and two specific precursors expressed in distinct embryonic territories; medial ganglionic eminence (MGE; Lhx6) and caudal ganglionic eminence (CGE)-entopeduncular and dorsal preoptic areas (AEP/PO; 5-HT~3A~).

Materials and Methods {#s1}
=====================

All experimental procedures were performed as described previously (Perrenoud et al., [@B50]) and were in accordance with the guidelines of the European Community Council Directive of November 24, 1986 (86/609/EEC).

Immunohistochemistry
--------------------

Seven P17 GAD67:GFP knock-in (Δneo) transgenic mice (Tamamaki et al., [@B56]), three offspring of Lhx6-CRE and Rosa26R-YFP mice (Fogarty et al., [@B17]), and three 5-HT~3A~:GFP mice (GENSAT, Vucurovic et al., [@B65]) were used. Mice were deeply anesthetized with an intraperitoneal (IP) injection of pentobarbital (150 mg/kg body weight) and perfused transcardially with 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS), pH 7.4 (PFA). Brains were dissected, embedded in 3% agarose diluted in PBS, and cut coronally on a vibratome (Leica; VT1000S). Free-floating 45 μm thick coronal sections were collected serially. Alternate sections were incubated for 48--72 h at 4°C with one of the following antibodies diluted in PBS containing triton (0.2%; PBST): rabbit anti-nNOS antibody (1:500; Santa-Cruz sc-648), rabbit anti-PV (1:800; Swant PV28), rat anti-SOM (1:500; Millipore MAB354), or rabbit anti-vasoactive intestinal peptide (VIP; 1:500, ImmunoStar 20077). After washing in PBST, sections were incubated with AlexaFluor 568 goat anti-rabbit antibody or AlexaFluor 568 goat anti-rat antibody (1:300; Invitrogen). Sections were rinsed in PBST, mounted in Vectashield (Vector) containing DAPI. Confocal images were acquired with an SP5 confocal microscope (Nikon).

Counting of GABAergic immunostained neurons
-------------------------------------------

Counting was performed using the method described in Perrenoud et al. ([@B50]). Briefly, immunostained slices of GAD67:GFP knock-in (Δneo) transgenic mice were observed with a fluorescent microscope (Zeiss, Axio Imager M1) equipped with an AxioCam MRm CCD camera (Zeiss). Mosaics were constructed from images spanning the region of the posteromedial barrel subfield (PMBSF; approximately between −0.94 and −2.06 mm from Bregma (Paxinos and Franklin, [@B49]), acquired using a 10× objective, with the AxioVision 4.7 software (Zeiss) and stored as gray scale bitmaps. Counts were performed using a procedure written in IGOR PRO 6 (WaveMetrics) with a custom made algorithm dividing the radial extent of the neocortex into 30 bins while following its curvature and adapting to variations in its thickness. Layer boundaries matched closely with edges of particular bins: layer I corresponded to bin 1 and 2; layer II/III to bin 3--9; layer IV to bin 10--13; layer V to bin 14--21; and layer VI to bin 22--30. Counts were repeated at least on three slices per animal. For each animal, final values of densities were computed, normalizing the sum of counted cells by the corresponding counted area.

Slice preparation for electrophysiological recordings
-----------------------------------------------------

Juvenile C57BL/6 mice (Janvier) aged P14--P17 were deeply anesthetized with halothane and decapitated. Brains were quickly removed and cut into 300 μm thick slices with a 30--40° inclination from the sagittal plane into an ice cold (approximately 4°C) slicing solution continuously aerated with carbogen (95% O~2~/5% CO~2~; Air Liquide), containing (in mM): 110 choline chloride, 11.6 sodium ascorbate, 7 MgCl~2~, 2.5 KCl, 1.25 NaH~2~PO~4~, 25 glucose, 25 NaHCO~3~, and 3.1 sodium pyruvate (Bureau et al., [@B3]). Prior to recording, slices were maintained at room temperature in a holding chamber containing artificial cerebrospinal fluid (aCSF) aerated with carbogen, containing (in mM): 126 NaCl, 2.5 KCl, 2 CaCl~2~, 1 MgCl~2~, 1.25 NaH~2~PO~4~, 20 glucose, and 26 NaHCO~3~. In order to avoid excitotoxicity 1 mM of kynurenic acid (Sigma) was added to the solution.

Whole-cell patch-clamp recordings
---------------------------------

Slices were submerged in thermostat controlled recording chamber (Luigs and Neuman), placed on the stage of an Axioskop 2FS microscope (Carl Zeiss), equipped with Dodt gradient contrast optics (Luigs and Neuman), and a CoolSnap FX CCD camera (Roper scientific) and visualized under infrared (IR) illumination. The preparation was continuously superfused (1--2 ml/min) with oxygenated aCSF. Barrels were visualized in the absence of the light condenser and recordings were performed within the barrel cortex. Pipettes (4--6 MΩ) were pulled from borosilicate capillaries and filled with 8 μl of autoclaved internal solution containing 144 mM K-gluconate, 3 mM MgCl~2~, 0.5 mM EGTA, 10 mM HEPES, pH 7.2 (285/295 mOsm), and 3 mg/ml biocytin (Sigma). Whole-cell recordings were performed at 30 ± 1°C in the current-clamp mode of a MultiClamp 700B amplifier (Molecular Devices). Signals were filtered at 4 kHz and digitized at 50 kHz with an analog signal converter (Digidata 1322A; Molecular Devices), and analyzed using pClamp 9.2 software (Molecular Devices). The sole criterion for selection of recorded cells was the absence of an apical dendrite. Junction potentials were not corrected.

Single-cell RT-PCR protocol
---------------------------

At the end of recordings, cytoplasms were aspirated into the patch pipette, expelled into a test tube in which reverse transcription was performed as described previously (Lambolez et al., [@B42]) and stored at −80°C. The scRT-PCR protocol was designed to detect the presence of messenger mRNAs coding for the vesicular glutamate transporter 1 (VGluT1), the two isoforms of glutamic acid decarboxylase (GAD65 and GAD67), nNOS, the calcium binding proteins calbindin (CB) 28k, calretinin (CR), and parvalbumin (PV), and the neuropeptides SOM, NPY, VIP, and cholecystokinin (CCK; Table [1](#T1){ref-type="table"}). Two successive rounds of amplification were performed using nested primer pairs (Cauli et al., [@B6]). All primer pairs (Table [1](#T1){ref-type="table"}) were designed to target two different exons so as to differentiate transcripts from genomic DNA. Amplification products were detected on 2% agarose gels in presence of a standard molecular weight marker (100 bp Ladder; Promega).

###### 

**PCR primer**.

  Genes         Size   First PCR primers                         Size   Second PCR primers
  ------------- ------ ----------------------------------------- ------ ---------------------------------------
  VGlut1        593    Sense, 124 CCCTTAGAACGGAGTCGGCT           367    Sense, 148 ACGACAGCCTTTTGCGGTTC
  NM_182993.1          Antisense, 697 TATCCGACCACCAGCAGCAG              Antisense, 495 CAAAGTAGGCGGGCTGAGAG
  GAD65         375    Sense, 99 CCAAAAGTTCACGGGCGG              248    Sense, 219 CACCTGCGACCAAAAACCCT
  NM_008078.1          Antisense, 454 TCCTCCAGATTTTGCGGTTG              Antisense, 447 GATTTTGCGGTTGGTCTGCC
  GAD67         253    Sense, 83 ATGATACTTGGTGTGGCGTAGC          177    Sense, 159 CAATAGCCTGGAAGAGAAGAGTCG
  NM_008077.3          Antisense, 314 GTTTGCTCCTCCCCGTTCTTAG            Antisense, 314 GTTTGCTCCTCCCCGTTCTTAG
  CA            426    Sense, 139 CGAAAGAAGGCTGGATTGGAG          295    Sense, 194 ATGGACAGAGAGATGATGGAAAAA
  NM_009788.2          Antisense, 544 CCCACACATTTTGATTCCCTG             Antisense, 467 TCCAGCTTTCCGTCATTATTTG
  CR            265    Sense, 83 TTGATGCTGACGGAAATGGGTA          151    Sense, 141 GCTGGAGAAGGCAAGGAAGG
  NM_007586.1          Antisense, 327 CAAGCCTCCATAAACTCAGCG             Antisense, 271 ATTCTCTTCGGTCGGCAGGAT
  PV            275    Sense, 104 GCCTGAAGAAAAAGAACCCG           163    Sense, 122 CGGATGAGGTGAAGAAGGTGT
  NM_013645.2          Antisense, 275 AATCTTGCCGTCCCCATCCT              Antisense, 265 TCCCCATCCTTGTCTCCAGC
  nNOS          373    Sense, 1668 CCTGGGGCTCAAATGGTATG          236    Sense, 1742 CCTGTCCCTTTAGTGGCTGGTA
  NM_008712.2          Antisense, 2021 CACAATCCACACCCAGTCGG             Antisense, 1957 GATGAAGGACTCGGTGGCAGA
  NPY           294    Sense, 16 CGAATGGGGCTGTGTGGA              220    Sense 38 CCCTCGCTCTATCTCTGCTCGT
  NM_023456.2          Antisense, 286 AAGTTTCATTTCCCATCACCACAT          Antisense, 236 GCGTTTTCTGTGCTTTCCTTCA
  SOM           250    Sense, 1 ATGCTGTCCTGCCGTCTCCA             170    Sense, 41 GCATCGTCCTGGCTTTGGG
  NM_009215.1          Antisense, 231 GCCTCATCTCGTCCTGCTCA              Antisense, 191 GGGCTCCAGGGCATCATTCT
  VIP           419    Sense, 3 GGAAGCCAGAAGCAAGCCTC             276    Sense, 113 TGGATGACAGGATGCCGTTT
  NM_011702.1          Antisense, 402 GCTTTCTGAGGCGGGTGTAG              Antisense, 369 CGGCATCAGAGTGTCGTTTG
  CCK           202    Sense, 259 ATACATCCAGCAGGTCCGCA           156    Sense, 305 CTTAAGAACCTGCAGAGCCTGG
  NM_031161.2          Antisense, 440 TTTCCTCATTCCACCTCCTCC             Antisense, 440 TTTCCTCATTCCACCTCCTCC

Histochemical labeling and morphological reconstruction of recorded neurons
---------------------------------------------------------------------------

Recorded slices were fixed overnight at 4°C with 4% paraformaldehyde in 0.1 M phosphate buffer (PB) pH 7.4 and kept in PB at 4°C until further processed. Slices were then sequentially incubated in PB containing 1% H~2~O~2~ in order to quench endogenous peroxidases, and in PB containing Avidin Biotin Complex (Vector; 1:200) and Triton X-100 (0.5%). Neuronal morphology was visualized using diaminobenzidine nickel (DAB elite kit, Vector). Between each step slices were thoroughly rinsed in PB. Tissue sections were mounted in Mowiol (Calbiochem). For recorded cells with clearly visible dendritic arborizations, morphology was analyzed using a DMR microscope (Leica), equipped with a 100× objective together with a standard Neurolucida system (MBF Bioscience).

Electrophysiological analysis
-----------------------------

Voltage responses of neurons induced by 800 ms hyperpolarizing and depolarizing current pulses were measured as described previously (Vucurovic et al., [@B65]; Perrenoud et al., [@B50]). In order to characterize the behavior of recorded neurons, 22 electrophysiological parameters were measured: (1) resting potential (RMP), (2) input resistance (*R*~m~), (3) membrane time constant (τ~m~), (4) membrane capacitance (*C*~m~), (5) Sag index, (6) rheobase, (7) first spike latency, (8) adaptation (*m*~threshold~), (9) minimal steady-state frequency (*F*~min~; slope and *y*-intercept of a linear fit to the firing frequency at threshold, respectively), (10) amplitude accommodation (*H*~ump~), (11) amplitude of early adaptation (*A*~sat~), (12) time constant of early adaptation (τ~sat~), (13) maximal steady-state frequency (*m*~sat~), and (14) late adaptation (*F*~max~; defined such that the function *F* = *A*~sat~ × exp(−*t*/τ~sat~) + *m*~sat~ × *t* + *F*~max~), was fitted to the firing frequency in the trace just prior to saturation (15) amplitude (A1), (16) duration (D1), (18) AHP maximum (AHP1m), (17) ADP, (19) AHP latencies (tAHP2m), and (20) ADP latencies of the first action potential, (21) amplitude reduction (Amp.Red), and (22) duration increase (Dur.Inc) of the second action potential relative to the first.

Morphological analysis
----------------------

Eighteen parameters related to features of the soma and dendrites of reconstructed neurons were extracted as described previously (Perrenoud et al., [@B50]). In order to describe somata of reconstructed neurons, (1) the area, (2) perimeter, (3) maximal, and (4) minimal diameters of the soma were computed from IR pictures acquired prior to whole-cell recording. (5) Elongation was defined as the ratio between the maximal and minimal diameters (Karagiannis et al., [@B36]). The dendritic properties of vectorized neurons were extracted using Neurolucida explorer (MBF Bioscience) and analyzed using Excel (Microsoft). The following parameters were quantified: (6) number of primary dendrites, (7) total dendritic length, (8) average length of segments, (9) ratio of the total dendritic length to the total dendritic surface, (10) average tortuosity of dendritic segments, (11) number of dendritic nodes, and (12) fractal index (calculated using the box counting method; Douketis et al., [@B12]). According to the Sholl procedure (Sholl, [@B54]): (13) The length of the dendritic arborization enclosed within a radius of 100 μm around the cell body, (14) between 100 and 200 μm radii, (15) between 200 and 300 μm radii, (16) and outside a 300-μm radius were extracted and expressed as a fraction of the total dendritic length. Finally, a wedge analysis was performed where the volume around each reconstructed neuron was divided into 12 wedges centered on the soma (Dumitriu et al., [@B14]; Vucurovic et al., [@B65]). (17) Vertical extent and (18) horizontal extent were defined as the fraction of the dendritic arborization, respectively, enclosed in the four wedges closest to the radial cortical axis or to the tangential cortical axis.

Unsupervised clustering
-----------------------

Using Ward's ([@B66]) method, cells are grouped in clusters so as to minimize the Euclidean distances between cells and cluster-centroids in multiparametric space. An advantage of this unsupervised clustering algorithm is that definition of the number of classes to be characterized is not required prior to analysis. However, a drawback of Ward's method is that miss-assigned cells are not corrected during the iterative process. Clusters generated with Ward's method were thus corrected using the K-means algorithm. This method initiates with *k* arbitrarily assigned cluster centers and assigns each observation to one of *k* corresponding clusters by minimizing the distance of the observation to the centers. The actual cluster-centroids are subsequently computed and the process is repeated until an optimum solution is reached whereby observations are allocated into *k* non-overlapping groups. Here, initial cluster centers were chosen so as to correspond to the centroids of the clusters generated with Ward's methods. This combination allowed the generation of non-overlapping clusters without making prior assumptions about the number of groups into which neurons should be separated. The threshold defining the number of clusters on Ward's dendrogram was set to the value maximizing the mean silhouette value of classified neurons after K-means correction. In silhouette analysis (Karagiannis et al., [@B36]), the value *S*(*i*) is computed for each data point as: *S*(*i*) = \[*b*(*i*) − *a*(*i*)\]/max\[*a*(*i*), *b*(*i*)\] where, for a data point *i*, *a*(*i*) corresponds to the average distance between *i* and the points belonging to the same cluster and *b*(*i*) corresponds to the average distance between *i* and the points of the closest cluster. In our case, a positive silhouette value indicates that on average, the neuron is closer to the neurons of its own cluster than from the neurons belonging to other clusters in the parameter space. By contrast, a negative value indicates a potential misclassification. Thus, a decrease of the mean silhouette value of the cells following randomization was interpreted as a lower quality of clustering. In order to maximize the consistency of the clustering results, parameters were not used for clustering (i) if they were dependent upon other parameters, (ii) if they were subjected to excessive variability from trial to trial, or (iii) if they were invariant in all observed cells. Based on these criteria, electrophysiological parameters used for clustering analysis were RMP, *R*~m~, τ~m~, *C*~m~, Sag index, *H*~ump~, *A*~sat~, *t*~sat~, *C*~sat~, *m*~sat~, A1, D1, AHP1max, tADP1, tAHP1max, Amp.Red, and Dur.Inc. Molecular parameters included in the clustering analysis were computed, as binary variables set to 1 if the marker was present and 0 if absent and corresponded to CB, PV, CR, NPY, VIP, and SOM. For all parameters, distributions were centered and reduced prior to clustering in order to eliminate any weighting effects induced by differences of scaling. This appeared sufficient to ensure that binary and continuous parameters had a similar effect on clustering analysis (Perrenoud et al., [@B50]).

Statistical analysis
--------------------

For electrophysiological and morphological variables, differences were tested using Kruskal--Wallis non-parametric ANOVAs followed by Mann--Whitney *U*-tests for pair comparisons. In order to test differences in the occurrence of molecular markers, we computed the statistic │ε│ = │*p*~a~ − *p*~b~│/√\[(*p*~q~/*n*~a~) + (*p*~q~/*n*~b~)\] where *p*~a~ and *p*~b~ represent the percentages of occurrence of the marker, and *n*~a~ and *n*~b~ the number of individuals in cluster a and b. The percentages of occurrence and of absence of the marker in the overall population were represented by *p* and *q* = 1 − *p*, respectively. *p*-Values of the difference of expression were computed by plotting this statistic against a standard normal distribution (Karagiannis et al., [@B36]). Variations in the density of labeled GABAergic cells between neocortical layers were tested using a one-way ANOVA on repeated measures test, followed by Student Newman--Keuls tests for pair comparisons. Kruskal--Wallis ANOVA, one-way ANOVA on repeated measures, and Student Newman--Keuls test were performed using Sigma Stat (LogiLabo). Mann--Whitney *U*-tests were performed within the Matlab environment (MathWorks) and statistical tests for molecular expression were performed in Excel (Microsoft).

Results
=======

Laminar distribution of type I and type II nNOS immunolabeled neurons
---------------------------------------------------------------------

The aim of this study was to characterize the populations of neocortical interneurons defined by nNOS immunoreactivity. In order to fulfill this goal we examined the density and the laminar distribution of these cells using immunohistochemistry. Cells defined by nNOS immunolabeling were counted in each layer of the barrel cortex from juvenile mice (P17; PMBSF; approximately between −0.94 and −2.06 mm from Bregma; Paxinos and Franklin, [@B49]). In order to ensure that all counted neurons were GABAergic, counts were performed on a strain of GAD67:GFP mice where GFP is thought to be restricted to and expressed in all GABAergic cells. Counts were normalized by the area of the counted region so as to provide a measure of density and were repeated on three animals. Counts were averaged between barrels and septa.

In agreement with previous reports (Yan et al., [@B73]; Yan and Garey, [@B72]; Smiley et al., [@B55]; Lee and Jeon, [@B43]) we found that two types of cells are defined on the basis of nNOS immunoreactivity. Type I cells corresponded to strongly labeled cells displaying large somata (Figure [1](#F1){ref-type="fig"}A2). By contrast, type II cells corresponded to smaller interneurons displaying weaker labeling, typically restricted to the perikaryon. The densities of these types of cell were assessed separately and each appeared to adopt a specific distribution and to concentrate in particular neocortical layers. Type I neurons were sparse (9.4 ± 2.7 cells/mm^2^ overall) and accumulated preferentially in layer VI where they had a density of 21.1 ± 7 cells/mm^2^. Type I neurons could be found at more moderate densities in layer V and layer II/III but were almost absent from layer I to IV (Figure [1](#F1){ref-type="fig"}B1). The overall density of type II neurons was higher than the density of type I neurons (18.3 ± 2.5 cells/mm^2^ overall). Type II neurons populated all neocortical layers but accumulated preferentially in layer II/III and layer VI (Figure [1](#F1){ref-type="fig"}B2).

![**Distribution of type I and type II nNOS-expressing GABAergic interneurons in the mouse barrel cortex**. **(A)** Colocalization of GFP **(1)** with nNOS immunolabeling **(2)** in GAD67:GFP mice. Arrows point to examples of type I (heavily labeled) nNOS-expressing GABAergic neurons and arrowheads point to examples of type II (weakly labeled) nNOS-expressing GABAergic cells. **(B)** Histogram of the density of type I **(1)** and type II **(2)** nNOS immunolabeled GFP-expressing cells in cortical layers I--VI (*n* = 3 mice; error bars: standard deviation; \*, \*\*, and \*\*\* indicate statistically significant differences with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; roman numerals refer to neocortical layers).](fncir-06-00036-g001){#F1}

Immunodetection of PV, SOM, and VIP in type I and type II nNOS interneurons
---------------------------------------------------------------------------

PV, SOM, and VIP immunoreactivity profiles define three well-characterized non-overlapping populations of interneurons in the cerebral cortex (Kubota et al., [@B40]; Gonchar and Burkhalter, [@B29]; Gonchar et al., [@B30]; Xu et al., [@B71]). In order to further characterize type I and type II nNOS-expressing interneurons, we investigated the expression of SOM, PV, and VIP using triple immunofluorescent labeling performed on GAD67:GFP knock-in mice. As apparent in Figures [2](#F2){ref-type="fig"}A,D1, 91.5 ± 4.0% of type I neurons expressed SOM. These results are consistent with previous reports indicating that SOM is a distinctive marker of type I neurons (Smiley et al., [@B55]). In agreement, only 11.0 ± 6.9% of type I neurons expressed PV and none expressed VIP (Figures [2](#F2){ref-type="fig"}E1,F1). By contrast, type II cells did not display a distinct immunoreactivity profile since PV, SOM, and VIP were expressed by 17.8 ± 5.0, 18.7 ± 6.9, and 10.2 ± 5.5% of type II interneurons, respectively. Interestingly, PV and SOM immunoreactive type II neurons were preferentially concentrated in deep neocortical layers while VIP immunoreactive type II neurons were located at the highest density in layers II/III (Figures [2](#F2){ref-type="fig"}D2,E2,F2). Thus, our results suggest that type II interneurons represent a heterogeneous population of interneurons.

![**Distributions of SOM, PV, and VIP expressing cells within type I and type II nNOS immunolabeled GABAergic interneurons**. **(A--C)** Colocalization of SOM, PV, and VIP **(1)** with nNOS immunolabeling **(2)** in GAD67:GFP knock-in mice. Arrows point to examples of type I (heavily labeled) nNOS-expressing neurons, arrowheads point to examples of type II nNOS (weakly labeled) expressing neurons. Double-labeled cells are marked by an asterisk. **(D--F)** Histograms reflecting the densities of SOM (green), PV (red), and VIP (blue) expressing neurons within type I **(1)** and type II **(2)** nNOS-GFP-expressing interneuron classes in cortical layers I--VI. The densities of doubled labeled cells are superimposed on the overall densities of nNOS type I (white) and nNOS type II (gray) interneurons (*n* = 3 mice; error bars: standard deviation; \*, \*\*, and \*\*\* indicate significant differences with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; roman numerals refer to neocortical layers).](fncir-06-00036-g002){#F2}

Characterization of interneurons expressing nNOS mRNA
-----------------------------------------------------

To further characterize nNOS-expressing interneurons, a sample of 42 cells expressing nNOS mRNA were selected from a large database of neocortical interneurons characterized *ex vivo* using whole-cell patch-clamp recordings coupled to scRT-PCR and biocytin labeling on juvenile mice (P17-P14). The properties of these neurons were quantified using a set of 49 defined parameters. Twenty-two electrophysiological parameters (Tables [2](#T2){ref-type="table"}--[5](#T5){ref-type="table"}) were measured from neuronal responses to hyperpolarizing and depolarizing current pulses. In accordance with the Petilla terminology (Ascoli et al., [@B2]), these parameters took into account passive membrane properties (five parameters, Table [2](#T2){ref-type="table"}), the properties of the discharges at threshold (four parameters, Table [3](#T3){ref-type="table"}), and saturation (five parameters, Table [4](#T4){ref-type="table"}), in addition to properties of action potentials (eight parameters, Table [5](#T5){ref-type="table"}). Nine molecular markers were detected by scRT-PCR alongside with nNOS: VGluT1, GAD \[i.e., expression of either glutamic acid decarboxylase 65K or glutamic acid decarboxylase 67K (GAD65 and GAD67)\], the calcium binding proteins CB, PV, and CR, and the neuropeptides NPY, VIP, SOM, and CCK (Figure [3](#F3){ref-type="fig"}). Finally, for a subset of 29 GABAergic neurons, morphological variables were measured from IR images of somata and from Neurolucida reconstructions of the dendritic trees. Eighteen morphometric parameters describing the soma (five parameters; Table [6](#T6){ref-type="table"}), the local features of the dendrites (seven parameters; Table [7](#T7){ref-type="table"}), and the spatial organization of the dendritic arborization (six parameters; Table [8](#T8){ref-type="table"}) were extracted for each cell. Due to the fact that high scRT-PCR efficiency requires that up to one third of the cytoplasmic content is harvested (Tsuzuki et al., [@B60]); a procedure which has a negative effect on biocytin labeling (Karagiannis et al., [@B36]; Vucurovic et al., [@B65]), characterization of the axon was not possible for every neuron analyzed for gene expression and electrophysiological behavior. Nevertheless, representative examples of axons were obtained cells in each identified population.

###### 

**Passive membrane properties**.

                                      Cluster 1 put-T2: Ad-NPY *n* = 19   Cluster 2 put-T1: Ad-SOM *n* = 7   Cluster 3 put-T2: non-Ad-PV/SOM *n* = 9   Cluster 4 put-T2: Ad-VIP/CR *n* = 7
  ----------------------------------- ----------------------------------- ---------------------------------- ----------------------------------------- -------------------------------------
  \(1\) Resting potential (mV)        −68.9 ± 4.1                         −65.4 ± 3.9                        −68.8 ± 4.7                               −64.1 ± 6.8
  ANOVA: N.S.                                                                                                                                          
  \(2\) Input resistance (MΩ)         359.7 ± 142.8                       519.7 ± 89.4                       303.1 ± 185.5                             546.5 ± 242.6
  ANOVA: 0.016                        \<C2                                \>C1, C3                           \<C2                                      
  \(3\) Membrane time constant (ms)   25.8 ± 14.2                         56.2 ± 24.3                        27.7 ± 14.6                               40.6 ± 12.4
  ANOVA: 0.004                        \<\<C2, \<C4                        \>\>C1, \>C3                       \<C2                                      \>C1
  \(4\) Membrane capacitance (pF)     71.8 ± 24.2                         113.8 ± 62.6                       99.5 ± 32.5                               106.2 ± 98.3
  ANOVA: N.S.                                                                                                                                          
  \(5\) Sag index (%)                 89.0 ± 4.0                          80.6 ± 11.4                        89.4 ± 4.7                                91.8 ± 5.2
  ANOVA: N.S.                                                                                                                                          

**n*, number of cells; N.S., non-significant; \<, \<\<, and \<\<\<, inferior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; \>, \>\>, and \>\>\>, superior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; C1, cluster 1; C2, cluster 2; C3, cluster 3; C4, cluster 4*.

###### 

**Just above threshold properties**.

                                              Cluster 1 put-T2: Ad-NPY *n* = 19   Cluster 2 put-T1: Ad-SOM *n* = 7   Cluster 3 put-T2: non-Ad-PV/SOM *n* = 9   Cluster 4 put-T2: Ad-VIP/CR *n* = 7
  ------------------------------------------- ----------------------------------- ---------------------------------- ----------------------------------------- -------------------------------------
  \(6\) Rheobase (pA)                         71.1 ± 33.1                         45.7 ± 35.1                        83.3 ± 63.6                               24.3 ± 9.8
  ANOVA: 0.001                                \>\>\>C4, \>C2                                                                                                   \<\<\<C1, C3
  \(7\) First spike latency (ms)              340.0 ± 242.2                       358.4 ± 225.0                      276.8 ± 183.1                             180.0 ± 89.4
  ANOVA: N.S.                                                                                                                                                  
  \(8\) Adaptation (Hz/s)                     3.5 ± 15.3                          −5.7 ± 22.8                        11.9 ± 110.0                              −4.2 ± 13.1
  ANOVA: N.S.                                                                                                                                                  
  \(9\) Minimal steady-state frequency (Hz)   6.8 ± 2.5                           14.5 ± 10.2                        16.9 ± 14.6                               8.3 ± 2.7
  ANOVA: N.S.                                                                                                                                                  

**n*, number of cells; N.S., non-significant; \<, \<\<, and \<\<\<, inferior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; \>, \>\>, and \>\>\>, superior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; C1, cluster 1; C2, cluster 2; C3, cluster 3; C4, cluster 4*.

###### 

**Firing properties**.

                                                 Cluster 1 put-T2: Ad-NPY *n* = 19   Cluster 2 put-T1: Ad-SOM *n* = 7   Cluster 3 put-T2: non-Ad-PV/SOM *n* = 9   Cluster 4 put-T2: Ad-VIP/CR *n* = 7
  ---------------------------------------------- ----------------------------------- ---------------------------------- ----------------------------------------- -------------------------------------
  \(10\) Amplitude accommodation (mV)            6.8 ± 5.2                           0.7 ± 1.2                          0.8 ± 1.2                                 1.7 ± 3.2
  ANOVA: \<0.001                                 \<\<\<C2, C3, \<\<C4                \>\>\>C1                           \>\>\>C1                                  \>\>C1
  \(11\) Amplitude of late adaptation (Hz)       112.5 ± 32.3                        54.4 ± 10.7                        37.8 ± 11.7                               42.7 ± 30.2
  ANOVA: \<0.001                                 \>\>\>C2, C3, C4                    \<\<\<C1, \<C3                     \<\<\<C1, \>C2                            \<\<\<C1
  \(12\) Time constant of late adaptation (ms)   20.2 ± 5.3                          27.7 ± 9.9                         16.9 ± 13.6                               33.6 ± 28.7
  ANOVA: N.S.                                    \<C2, \>C3                          \>C1, C3                           \<C1, C2                                  
  \(13\) Maximal steady-state frequency (Hz)     84.6 ± 17.0                         93.5 ± 35.8                        164.9 ± 25.2                              61.8 ± 12.9
  ANOVA: \<0.001                                 \<\<\<C3, \>\>C4                    \<\<C3                             \>\>\>C1, C4, \>\>C2                      \<\<\<C3, \<\<C1
  \(14\) Late adaptation (Hz/s)                  −27.4 ± 12.8                        −22.1 ± 14.1                       −31.4 ± 16.2                              −13.5 ± 12.3
  ANOVA: N.S.                                                                                                                                                     

**n*, number of cells; N.S., non-significant; \<, \<\<, and \<\<\<, inferior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; \>, \>\>, and \>\>\>, superior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; C1, cluster 1; C2, cluster 2; C3, cluster 3; C4, cluster 4*.

###### 

**Action potential properties**.

                                            Cluster 1 put-T2: Ad-NPY *n* = 19   Cluster 2 put-T1: Ad-SOM *n* = 7   Cluster 3 put-T2: non-Ad-PV/SOM *n* = 9   Cluster 4 put-T2: Ad-VIP/CR *n* = 7
  ----------------------------------------- ----------------------------------- ---------------------------------- ----------------------------------------- -------------------------------------
  \(15\) First spike amplitude (mV)         72.1 ± 7.2                          69.3 ± 8.8                         70.3 ± 5.8                                78.0 ± 8.2
  ANOVA: N.S.                                                                                                                                                
  \(16\) First spike duration (ms)          1.0 ± 0.2                           0.9 ± 0.2                          0.6 ± 0.1                                 0.8 ± 0.1
  ANOVA: \<0.001                            \>\>\>C3                            \>\>\>C3                           \<\<\<C1, C2, C4                          \>\>\>C3
  \(17\) First spike ADP (mV)               0.1 ± 0.4                           0.0 ± 0.0                          0.0 ± 0.0                                 1.8 ± 1.9
  ANOVA: \<0.001                            \<\<C4                              \<\<C4                             \<C4                                      \>\>C1, C3, \>C2
  \(18\) First spike AHP maximum (mV)       −21.3 ± 4.2                         −22.9 ± 4.0                        −25.5 ± 3.6                               −16.2 ± 6.1
  ANOVA: 0.007                              \>\>C3                              \<C4                               \<\<C1, C4                                \>\>C3, \>C2
  \(19\) First spike ADP latency (ms)       0.8 ± 2.3                           0.0 ± 0.0                          0.0 ± 0.0                                 7.1 ± 5.2
  ANOVA: \<0.001                            \<\<C4                              \<\<C4                             \<C4                                      \>\>C1, C3, \>C2
  \(20\) First spike AHP max latency (ms)   12.9 ± 6.2                          4.4 ± 4.0                          2.1 ± 0.3                                 7.4 ± 11.2
  ANOVA: \<0.001                            \>\>\>C3, \>\>C2, \>C4              \>\>\>C3, \<\<C1                   \<\<\<C1, C2, C4                          \>\>\>C3, \<C1
  \(21\) Amplitude reduction (%)            0.9 ± 2.6                           3.0 ± 9.8                          −1.8 ± 5.5                                4.0 ± 2.7
  ANOVA: N.S.                                                                                                                                                
  \(22\) Duration increase (%)              4.7 ± 2.8                           4.4 ± 8.2                          0.1 ± 3.0                                 6.6 ± 1.9
  ANOVA: 0.004                              \>\>C3                                                                 \<\<\<C4, \<\<C1                          \>\>\>C3

**n*, number of cells; N.S., non-significant; \<, \<\<, and \<\<\<, inferior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; \>, \>\>, and \>\>\>, superior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; C1, cluster 1; C2, cluster 2; C3, cluster 3; C4, cluster 4*.

![**Clustering of interneurons expressing nNOS mRNA**. **(A)** Ward's clustering of 42 nNOS interneurons sampled from slices of the barrel cortex of juvenile (P14--P17) mice. Individual cells are represented along the *x*-axis. The *y*-axis represents the distance of aggregation in a space of 17 electrophysiological variables and 6 molecular markers. Four clusters, termed Adapt-NPY (cluster 1, yellow), Adapt-SOM (cluster 2, green), non-Ad-PV/SOM (cluster 3, red), and Adapt-VIP/CR (cluster 4, blue) were identified. **(B)** Table corresponding to Ward's clustering in **(A)** and a clustering output generated by the K-means algorithm with the same sample and parameters with non-overlapping components in gray font. Note that the clusters are mostly overlapping. **(C)** Laminar distribution of cluster 2. Note that the distribution is consistent with the distribution of type I nNOS immunolabeled neurons (Figure [1](#F1){ref-type="fig"}). **(D)** Cumulated laminar distribution of clusters 1 (yellow), 3 (red), and 4 (blue). Note that the distribution is consistent with the distribution of type II nNOS immunolabeled neurons (Figure [1](#F1){ref-type="fig"}). **(E)** Histograms of the expression of Vglut1, GAD, CB, PV, CR, NPY, VIP, SOM, and CCK in clusters 1, 2, 3, and 4. Note that the expression of SOM mRNA in cluster 2 closely resembles the profile of SOM expression in type I nNOS immunolabeled neurons (Figure [2](#F2){ref-type="fig"}) while this is not the case for other clusters (green contour on histogram bars; C1: cluster 1; C2 cluster 2; C3: cluster 3; C4: cluster 4; \*, \*\*, and \*\*\* indicate significant differences with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively). **(F)** Representative examples of electrophysiological properties (left and right panels) and morphology (central panel) from neurons from clusters 1 (yellow, upper left), 2 (green, lower left), 3 (red, lower right), and 4 (blue, upper right). Electrophysiological traces correspond to voltage responses induced by current injections (bottom traces: −100 to 0 pA by increments of 10 pA and rheobase; top trace: last step of current before saturation). For the morphological reconstructions of corresponding neurons, somatodendritic trees are illustrated in black, axons in red. Neurons are represented at their respective laminar positions.](fncir-06-00036-g003){#F3}

###### 

**Soma under infrared microscopy**.

                                Cluster 1 put-T2: Ad-NPY *n* = 18   Cluster 2 put-T1: Ad-SOM *n* = 6   Cluster 3 put-T2: non-Ad-PV/SOM *n* = 9   Cluster 4 put-T2: Ad-VIP/CR *n* = 7
  ----------------------------- ----------------------------------- ---------------------------------- ----------------------------------------- -------------------------------------
  \(1\) Area (μm^2^)            125.6 ± 31.8                        151.4 ± 27.8                       170.2 ± 52.8                              131.5 ± 28.5
  ANOVA: N.S.                                                                                                                                    
  \(2\) Perimeter (μm)          42.0 ± 5.6                          45.6 ± 5.1                         49.5 ± 9.4                                47.9 ± 9.6
  ANOVA: N.S.                                                                                                                                    
  \(3\) Maximal diameter (μm)   15.3 ± 2.4                          16.3 ± 1.9                         17.8 ± 4.1                                19.6 ± 5.0
  ANOVA: N.S.                                                                                                                                    
  \(4\) Minimal diameter (μm)   10.3 ± 1.5                          11.7 ± 1.3                         12.0 ± 1.6                                9.1 ± 0.9
  ANOVA: 0.002                  \<C2, C3                            \>\>C4, \>C1                       \>\>C4, \>C1                              \<\<C2, C3
  \(5\) Elongation              1.5 ± 0.3                           1.4 ± 0.2                          1.5 ± 0.3                                 2.2 ± 0.6
  ANOVA: 0.038                  \<C4                                \<C4                               \<C4                                      \>C1, C2, C3

**n*, number of cells; N.S., non-significant; \<, \<\<, and \<\<\<, inferior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; \>, \>\>, and \>\>\>, superior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; C1, cluster 1; C2, cluster 2; C3, cluster 3; C4, cluster 4*.

###### 

**Local metric of dendrites**.

                                                   Cluster 1 put-T2: Ad-NPY *n* = 11   Cluster 2 put-T1: Ad-SOM *n* = 6   Cluster 3 put-T2: non-Ad-PV/SOM *n* = 8   Cluster 4 put-T2: Ad-VIP/CR *n* = 4
  ------------------------------------------------ ----------------------------------- ---------------------------------- ----------------------------------------- -------------------------------------
  \(6\) Number of primary dendrites                8.0 ± 1.9                           5.0 ± 1.9                          6.4 ± 1.4                                 3.3 ± 1.5
  ANOVA: 0.003                                     \>\>C4, \>C2                        \<C1                               \>C4                                      \<\<C1, \<C3
  \(7\) Total dentritic length (μm)                2073.0 ± 1063.2                     2127.8 ± 1066.0                    2101.9 ± 825.6                            2298.8 ± 1016.2
  ANOVA: N.S.                                                                                                                                                       
  \(8\) Length of segments (average; μm)           28.2 ± 9.7                          51.0 ± 16.4                        47.9 ± 12.9                               44.9 ± 16.0
  ANOVA: 0.005                                     \<\<C2, C3, \<C4                    \>\>C1                             \>\>C1                                    \>C1
  \(9\) Length/surface                             0.97 ± 0.18                         0.82 ± 0.38                        0.80 ± 0.23                               0.96 ± 0.26
  ANOVA: N.S.                                                                                                                                                       
  \(10\) Dendritic segments tortuosity (average)   1.18 ± 0.03                         1.19 ± 0.06                        1.18 ± 0.05                               1.22 ± 0.07
  ANOVA: N.S.                                                                                                                                                       
  \(11\) Number of nodes                           31.6 ± 11.5                         18.5 ± 10.6                        18.8 ± 6.0                                27.5 ± 17.9
  ANOVA: N.S.                                                                                                                                                       
  \(12\) Fractal index                             1.11 ± 0.04                         1.08 ± 0.03                        1.08 ± 0.03                               1.11 ± 0.05
  ANOVA: N.S.                                                                                                                                                       

**n*, number of cells; N.S., non-significant; \<, \<\<, and \<\<\<, inferior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; \>, \>\>, and \>\>\>, superior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; C1, cluster 1; C2, cluster 2; C3, cluster 3; C4, cluster 4*.

###### 

**Spatial distribution of the dendritic arbor**.

                                            Cluster 1 put-T2: Ad-NPY *n* = 11   Cluster 2 put-T1: Ad-SOM *n* = 6   Cluster 3 put-T2: non-Ad-PV/SOM *n* = 8   Cluster 4 put-T2: Ad-VIP/CR *n* = 4
  ----------------------------------------- ----------------------------------- ---------------------------------- ----------------------------------------- -------------------------------------
  \(13\) Dendritic Sholl (0--100 μm; %)     85.1 ± 19.6                         56.1 ± 17.2                        59.3 ± 12.1                               54.4 ± 23.9
  ANOVA: 0,01                               \>\>C3, \>C2, C4                    \>C1                               \>\>C1                                    \>C1
  \(14\) Dendritic Sholl (100--200 μm; %)   12.4 ± 13.2                         32.9 ± 10.0                        32.5 ± 9.1                                32.6 ± 12.2
  ANOVA: 0.008                              \<\<C2, C3, \<C4                    \>\>C1                             \>\>C1                                    \>C1
  \(15\) Dendritic Sholl (200--300 μm; %)   2.2 ± 7.3                           10.4 ± 10.3                        7.9 ± 7.3                                 11.2 ± 13.8
  ANOVA: 0.025                              \<\<C3, \<C2                        \>C1                                                                         
  \(16\) Dendritic Sholl (\>300 μm; %)      0.2 ± 0.7                           0.6 ± 1.4                          0.3 ± 0.7                                 1.7 ± 3.5
  ANOVA: N.S.                                                                                                                                                
  \(17\) Vertical extent (%)                40.8 ± 13.6                         42.9 ± 22.6                        43.9 ± 20.2                               60.3 ± 28.0
  ANOVA: N.S.                                                                                                                                                
  \(18\) Horizontal extent (%)              30.6 ± 13.2                         31.6 ± 15.5                        29.2 ± 14.5                               19.6 ± 19.6
  ANOVA: N.S.                                                                                                                                                

**n*, number of cells; N.S., non-significant; \<, \<\<, and \<\<\<, inferior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; \>, \>\>, and \>\>\>, superior with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; C1, cluster 1; C2, cluster 2; C3, cluster 3; C4, cluster 4*.

Unsupervised classification of interneurons expressing nNOS mRNA
----------------------------------------------------------------

In order to determine whether interneurons expressing nNOS mRNA can be divided into subgroups based on functional and molecular parameters, we applied Ward's method; an algorithm which has been widely used in the categorization of interneurons (Tamas et al., [@B57]; Cauli et al., [@B7]; Gallopin et al., [@B23]). Ward's clustering was applied on the basis of 17 electrophysiological variables and 6 molecular parameters representing the properties of sampled neurons (see [Materials and Methods](#s1){ref-type="sec"}). As illustrated in the resulting aggregation dendrogram (Figure [3](#F3){ref-type="fig"}A), four groups of cells could be identified in our sample of nNOS transcribing neurons. These groups were designated as clusters 1, 2, 3, and 4 and represented 20, 5, 9, and 8 neurons, respectively. As outlined previously (see [Materials and Methods](#s1){ref-type="sec"}), due to its iterative nature, Ward's method has the advantage that no assumptions are required regarding the number of groups into which observations should be classified. However, a drawback of this method is that miss-assigned cells are not corrected through the iterative process. So as to eliminate potential mistakes occurring, Ward's clusters were corrected using the K-means algorithm (see [Materials and Methods](#s1){ref-type="sec"}, Karagiannis et al., [@B36]; McGarry et al., [@B45]; Perrenoud et al., [@B50]). Following correction, two cells of cluster 1 were reassigned to cluster 2, and one neuron of cluster 4 was reassigned to cluster 1 (Figure [3](#F3){ref-type="fig"}B). In order to determine whether the allocation of neurons into four groups based on these parameters was the optimal outcome of the clustering process, our results were compared with clustering trials whereby thresholds were set to define fewer or higher numbers of groups. After K-means correction, the mean silhouette value for cluster analysis yielding four groups was 0.3014 (see [Materials and Methods](#s1){ref-type="sec"}; Karagiannis et al., [@B36]; McGarry et al., [@B45]; Perrenoud et al., [@B50]). By comparison, clusterings obtained after correction for three or five groups resulted in smaller mean silhouette values (0.2879 and 0.2023, respectively), indicating a loss of clustering quality. Thus, the subdivision of neurons into four groups was retained for further analysis. The neurons of clusters 1, 2, and 3 displayed adapting action potential discharges and were characterized by a high expression of NPY, SOM, and VIP/CR, respectively. These clusters were thus named adapting NPY (Adapt-NPY), adapting SOM (Adapt-SOM), and adapting VIP/CR (Adapt-VIP/CR). By contrast, cluster 4 neurons showed little adaptation of firing frequencies and expressed PV or SOM. Cluster 4 was thus termed non-adapting PV/SOM (non-Ad-PV/SOM).

Identification of putative type I and type II cells within interneurons expressing nNOS mRNA
--------------------------------------------------------------------------------------------

To determine whether identified clusters of cells expressing nNOS mRNA could correspond to type I or type II nNOS immunoreactivity, we examined the laminar distribution of nNOS neurons (Figures [3](#F3){ref-type="fig"}C,D) and their expression of the molecular markers PV, SOM, and VIP (Figure [3](#F3){ref-type="fig"}E). Particular attention was paid to the level of transcription of SOM as the expression of this marker was a distinctive feature of type I neurons at the protein level (Figure [2](#F2){ref-type="fig"}C2). As apparent in Figure [3](#F3){ref-type="fig"}E, SOM was present in 85.7% of the neurons in cluster 2 (Adapt-SOM), a proportion highly consistent with the level of expression of SOM in type I interneurons. The laminar distribution of neurons within cluster 2 (Figure [3](#F3){ref-type="fig"}C) also appeared to replicate the distribution of type I neurons as assessed by immunohistochemistry (Figure [1](#F1){ref-type="fig"}B1). The cumulated laminar distribution (Figure [3](#F3){ref-type="fig"}D) and levels of PV, SOM, and VIP expression for neurons in clusters 1, 3, and 4 (Figure [3](#F3){ref-type="fig"}F) also appeared to be in strong agreement with results obtained at the protein level for type II neurons (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Consistent with the expression of PV and SOM in deep layer type II neurons (Figures [2](#F2){ref-type="fig"}C2,D2), these mRNAs were highly expressed in neurons within cluster 3 (non-Ad-PV/SOM) which were preferentially found in layer VI (Figures [3](#F3){ref-type="fig"}D,E). In addition, the expression of VIP in superficial type II neurons (Figure [2](#F2){ref-type="fig"}E2) corresponded reasonably well with the high levels of VIP expression (Figure [3](#F3){ref-type="fig"}E) and the preferential localization in layers II/III of cluster 4 neurons (Adapt-VIP/CR; Figure [3](#F3){ref-type="fig"}D). Thus, based on the striking agreement of our multiparametric results with the distribution and marker expression of type I and type II nNOS-expressing neurons, cluster 2 cells were identified as putative type I interneurons, while neurons within clusters 1, 3, and 4 were identified as putative type II cells. To further investigate this hypothesis, we next undertook a multiparametric characterization of putative type I and type II nNOS-expressing neurons.

Multiparametric characteristics of putative type I interneurons
---------------------------------------------------------------

Putative type I neurons belonging to the Adapt-SOM cluster (*n* = 7) displayed distinctive properties. Electrophysiological data showed that putative type I neurons were characterized by medium to high input resistances and significantly higher membrane time constants than the neurons of other clusters (Table [2](#T2){ref-type="table"}). They displayed a marked adaptation of frequency at threshold (Table [3](#T3){ref-type="table"}) and saturation (Table [4](#T4){ref-type="table"}) and fired long duration spikes followed by fast AHPs (Table [5](#T5){ref-type="table"}; Figure [3](#F3){ref-type="fig"}F). Alongside their previously mentioned high expression of SOM, putative type I neurons displayed significantly higher levels of CB (100%) and NPY (100%) than neurons in other clusters (Figure [3](#F3){ref-type="fig"}E). Putative type I neurons typically displayed large somata (Table [6](#T6){ref-type="table"}), exhibiting an average of five primary dendrites (Table [7](#T7){ref-type="table"}), which ramified to form a wide dendritic arbor extending up to 300 μm away from the cell body (Table [8](#T8){ref-type="table"}). The axon of two putative type I cells could be reconstructed to a length in excess of 1 mm and appeared to ramify extensively within the layer of origin (illustrated in Figure [3](#F3){ref-type="fig"}F). Finally, concurring with immunohistochemical results, putative type I neurons were principally sampled in layer VI (six of seven neurons) but also occurred in layer II/III (one of seven neurons; Figure [3](#F3){ref-type="fig"}D).

Multiparametric characteristics of putative type II interneurons
----------------------------------------------------------------

Our results suggest that type II neurons comprise three populations of neurons, each with distinct characteristics: Adapt-NPY (cluster 1), non-Ad-PV/SOM (cluster 3), and Adapt-VIP/CR (cluster 4). Adapt-NPY neurons (*n* = 19) populated all neocortical layers but were most abundant in layers II/III and VI (Figure [3](#F3){ref-type="fig"}D). Electrophysiological data showed that Adapt-NPY were characterized by medium range input resistances (Table [2](#T2){ref-type="table"}). Their action potential discharges were accelerating at threshold (Table [3](#T3){ref-type="table"}), adapting at saturation and displayed a significantly larger accommodation of spike amplitude than for neurons in other clusters (Table [4](#T4){ref-type="table"}). Adapt-NPY neurons displayed long duration action potential spikes and were characterized by significantly slower AHP duration than other neurons (Table [5](#T5){ref-type="table"}). Interestingly, Adapt-NPY neurons did not show a notable expression of calcium binding proteins such as PV, CB, or CR (Figure [3](#F3){ref-type="fig"}E). Alongside NPY (100%), they mostly expressed CCK (52.6%). Finally, Adapt-NPY neurons showed a highly distinctive morphological profile. They had small somata (Table [6](#T6){ref-type="table"}) and exhibited a significantly higher number of primary dendrites than other neurons (Table [7](#T7){ref-type="table"}). Their dendrites ramified extensively (Table [7](#T7){ref-type="table"}) and tended to stay confined within a radius of 200 μm around the soma (Table [8](#T8){ref-type="table"}). The axons of three cells could be reconstructed extending in excess of 1 mm and also appeared to ramify extensively around the cell body. These characteristics suggest that Adapt-NPY very likely correspond to neurogliaform cells (Kawaguchi, [@B39]).

Non-Ad-PV/SOM neurons (*n* = 9) were principally sampled in layer VI (seven of nine neurons) and displayed the most distinctive electrophysiological characteristic of our sample. They had depolarized membrane potentials and short time constants (Table [2](#T2){ref-type="table"}). They showed little or no adaptation at threshold (Table [3](#T3){ref-type="table"}), fired at a significantly higher maximal rate (Table [4](#T4){ref-type="table"}), with significantly faster spike durations and AHP dynamics than other neurons (Table [5](#T5){ref-type="table"}). Non-Ad-PV/SOM expressed either PV (66.7%) or SOM (33.3%) but never co-expressed both markers. They were also characterized by a high occurrence of CCK expression (66.7%). Finally, on a morphological basis, non-Ad-PV/SOM neurons appeared as multipolar cells with large somata. The axon of one non-Ad-PV/SOM was reconstructed extending in excess of 1 mm from the soma and appeared to ramify within its layer of origin (Figure [3](#F3){ref-type="fig"}F).

Adapt-VIP/CR neurons (*n* = 7) appeared to concentrate preferentially in superficial layers (Figure [3](#F3){ref-type="fig"}D). They were characterized by high input resistances (Table [2](#T2){ref-type="table"}), low rheobases, adapting discharges at threshold (Table [3](#T3){ref-type="table"}) and saturation, and fired at significantly lower maximal frequencies than other neurons (Table [4](#T4){ref-type="table"}). Some of them displayed double AHPs (Table [5](#T5){ref-type="table"}). They mostly expressed CR (85.7%) and VIP (71.4%; Figure [3](#F3){ref-type="fig"}E). On a morphological basis, they appeared as fusiform neurons, having significantly higher soma aspect ratio than other neurons (Table [6](#T6){ref-type="table"}). Most of them were of bipolar morphology resulting in a significantly lower number of dendrites than other cells (Table [7](#T7){ref-type="table"}). The axon of one Adapt-VIP/CR was reconstructed in excess of 1 mm and appeared to be descending (Figure [3](#F3){ref-type="fig"}F).

Embryonic origin of type I and type II nNOS-expressing interneurons
-------------------------------------------------------------------

Most neocortical interneurons originate in the embryonic subpallium (Wonders and Anderson, [@B68]). This region is subdivided into several progenitor domains each giving rise to specific populations of interneurons (Gelman and Marin, [@B27]). In order to complement the characterization of nNOS-expressing interneurons, we attempted to obtain insight about their embryonic origins. To achieve this goal, we performed nNOS immunostaining in two transgenic mouse lines where specific and non-overlapping regions of the subpallium are labeled with fluorescent proteins (Flames et al., [@B16]; Fogarty et al., [@B17]; Lee et al., [@B44]; Vucurovic et al., [@B65]; Vitalis and Rossier, [@B63]): Lhx6-Cre/R26R-YFP mice (Figure [4](#F4){ref-type="fig"}A) where fluorescence is found in neurons originating from the MGE and 5-HT~3A~:GFP mice (Figure [4](#F4){ref-type="fig"}B) where labeled neurons originate in the CGE, and in the AEP/PO. Nearly all type I neurons (98.6 ± 2.5%) expressed GFP in Lhx6-Cre/R26R-YFP (Figure [4](#F4){ref-type="fig"}C1) indicating that all originate in the MGE. Accordingly type I neurons never expressed GFP in 5-HT~3A~:GFP mice (Figure [4](#F4){ref-type="fig"}D1). By contrast 63.0 ± 6.8% of type II neurons expressed GFP in Lhx6-Cre/R26R-YFP mice while 34.4 ± 0.9% were labeled in 5-HT~3A~:GFP mice (Figures [4](#F4){ref-type="fig"}C2,D2). This indicated that type II neurons comprise neurons originating both in the CGE-AEP/PO and the MGE, reinforcing the idea that they form a heterogeneous population. Interestingly, GFP-expressing type II neurons appeared to accumulate in deeper layers in Lhx6-Cre/R26R-YFP mice while they accumulated in upper neocortical layers in 5-HT~3A~:GFP.

![**Distributions of GFP-expressing cells among type I and type II nNOS immunolabeled neurons in Lhx6-Cre/R26R-YFP and 5-HT~3A~:GFP mice**. **(A)** Colocalization of GFP **(1)** with nNOS immunolabeling **(2)** in Lhx6-Cre/R26R-YFP. **(B)** Colocalization of GFP **(1)** with nNOS immunolabeling **(2)** in 5-HT~3A~:GFP mice. Arrows point to examples of type I (heavily labeled) nNOS-expressing neurons, arrowheads point to examples of type II nNOS (weakly labeled) expressing neurons. Double-labeled cells are marked by an asterisk. **(C)** Histograms reflecting the density of GFP-expressing type I **(1)** and type II **(2)** nNOS immunolabeled cells in cortical layer I--VI of Lhx6-Cre/R26R-YFP mice (yellow). **(D)** Histograms reflecting the density of GFP-expressing type I **(1)** and type II **(2)** nNOS immunolabeled cells in cortical layer I--VI of 5-HT~3A~:GFP mice (blue). In **(C)** and **(D)** the densities of nNOS type I (white) and nNOS type II (gray) neurons are superimposed (*n* = 3 mice; error bars: standard deviation; \*, \*\*, and \*\*\* indicate significant differences with *p* ≤ 0.05, *p* ≤ 0.01, and *p* ≤ 0.001, respectively; roman numerals refer to neocortical layers).](fncir-06-00036-g004){#F4}

Discussion
==========

In this study, we characterized neocortical nitrergic neurons using a multi-disciplinary approach combining immunohistochemical labeling of nNOS-expressing neurons and multiparametric analysis of nNOS transcribing neurons in acute slices of mouse somatosensory barrel cortex. We found that type I cells constitute a relatively homogeneous population of interneurons originating from MGE as a specific embryonic territory. In contrast, type II cells are divided into three interneuron subtypes originating from the MGE as well as the CGE-AEP/PO.

Characterization of neocortical nitrergic interneurons
------------------------------------------------------

In the neocortex, as is apparent using immunohistochemistry or NADPH diaphorase immunoreactivity, nNOS concentrates in a sparse population of GABAergic neurons which subdivide in two subtypes: heavily labeled type I cells and lightly labeled type II cells (Yan et al., [@B73]; Yan and Garey, [@B72]; Smiley et al., [@B55]; Lee and Jeon, [@B43]). However, these nitrergic neurons remain poorly characterized (Kilduff et al., [@B37]). Although the molecular identity of types I nitrergic neurons has been well investigated in primate and rodents (Estrada and Defelipe, [@B15]), very few studies have characterized the expression of markers of interneurons in type II cells (Kubota et al., [@B41]). In addition, due to their paucity, electrophysiological recordings of nitrergic interneurons have rarely been achieved in brain slices (Cauli et al., [@B8]; Karagiannis et al., [@B36]). Therefore, our understanding of the neocortical mechanisms underlying NO release as a response to neuronal activity remains elusive.

In this study, the properties of type I and type II neocortical nitrergic interneurons were extensively characterized in the barrel cortex of juvenile (P14--17) mouse. Firstly, using nNOS immunohistochemistry in GAD67:GFP knock-in mice (Tamamaki et al., [@B56]), we described the laminar distribution of type I and type II nitrergic interneurons. Using double labeling immunohistochemistry, the molecular properties of the two classes of neurons was investigated by assessing their expression of PV, SOM, and VIP which constitute non-overlapping markers whose expression is restricted to specific interneuron populations (Kubota et al., [@B40], [@B41]; Gonchar and Burkhalter, [@B29]; Gonchar et al., [@B30]; Xu et al., [@B71]). Secondly, we analyzed the properties of 42 interneurons expressing nNOS mRNA and characterized with patch-clamp recordings combined with biocytin labeling and scRT-PCR. This sample of cells was extracted from a dataset of more than 300 interneurons harvested in all layers of the barrel cortex (20 of the cells used in this study were also used in a previous report; Perrenoud et al., [@B50]). Unsupervised cluster analysis (see [Materials and Methods](#s1){ref-type="sec"} and Perrenoud et al., [@B50]), disclosed four groups of nitrergic neurons exhibiting distinct electrophysiological, molecular, and morphological properties. Interestingly, by analyzing the laminar distribution and the molecular markers transcribed in these groups, each could be putatively related to type I or type II immunoreactivity. Finally, we provided insights into the embryonic origin of type I and type II nitrergic interneurons by using immunohistochemistry on two mouse strains (Lhx6-Cre/R26R-YFP and 5-HT~3A~:GFP) in which interneurons originating from specific regions of the embryonic subpallium are identified by GFP fluorescence (Du et al., [@B13]; Lee et al., [@B44]; Vucurovic et al., [@B65]).

Together these data provide a comprehensive characterization of neocortical nitrergic neurons. As detailed in the following section, the results generated using different approaches in this study were strikingly coherent and resulted in a consistent picture of the properties of type I and type II nNOS-expressing cells. Thus, we are confident that our results constitute an accurate description of the properties of nitrergic neurons in the barrel cortex of juvenile mouse.

Type I interneurons are SOM-expressing cells originating from the MGE
---------------------------------------------------------------------

Type I nitrergic neurons are the object of considerable attention because of their unique properties. Firstly, though they are GABAergic (Valtschanoff et al., [@B61]), they differ from other neocortical inhibitory neurons in that they send long distance horizontal projections to remote neocortical areas (Tomioka et al., [@B58]; Higo et al., [@B33], [@B32]; Tomioka and Rockland, [@B59]). Thus, although they constitute a subset of the so-called "neocortical interneurons," type I nitrergic cells are not interneurons *per se*. Interestingly, it has also been recently demonstrated that type I neurons are specifically activated during a long period of slow wave sleep obtained after sleep deprivation (Gerashchenko et al., [@B28]; Kilduff et al., [@B37]).

Our study confirms and significantly improves current descriptions of type I nitrergic neocortical neurons. As reported in other studies, type I interneurons displayed intense nNOS immunoreactivities (Yan et al., [@B73]; Yan and Garey, [@B72]; Smiley et al., [@B55]; Lee and Jeon, [@B43]) and preferentially populated layer VI and V (Vercelli et al., [@B62]; Wiencken and Casagrande, [@B67]; Garbossa et al., [@B24]; Lee and Jeon, [@B43]). By comparison, they were less frequent in layer II/III and relatively infrequent in layers I and IV. Combined immunofluorescent labeling revealed that type I interneurons predominantly expressed SOM, confirming that they constitute a subset of SOM-expressing interneurons (Kubota et al., [@B40], [@B41]; Smiley et al., [@B55]; Karagiannis et al., [@B36]). However, although rarely, PV immunoreactivity was detected in some type I cells, as reported in the mouse visual cortex (Lee and Jeon, [@B43]).

The electrophysiological properties of type I cells have been largely neglected due to the scarcity of these cells in the cortex (Kilduff et al., [@B37]). Here we performed unsupervised cluster analysis on a sample of interneurons expressing nNOS mRNA, disclosing a cluster of cells (Adapt-SOM) that likely correspond to type I interneurons. Indeed, these neurons were mainly recorded in deep layers and co-expressed SOM and NPY mRNAs well-matching with the features of type I cells (Kubota et al., [@B40], [@B41]; Karagiannis et al., [@B36]). Putative type I cells displayed adapting discharges, fired long duration action potential spikes followed by fast AHPs and had significantly slower membrane time constant than other interneurons (Table [2](#T2){ref-type="table"}). Type I cells had large somas (Table [6](#T6){ref-type="table"}) and displayed an average of five primary dendrites (Table [7](#T7){ref-type="table"}) which ramified into a wide arbor (Table [8](#T8){ref-type="table"}). The axon of one putative type I cell could be satisfactorily reconstructed and appeared to ramify extensively within its layer of origin (Figure [3](#F3){ref-type="fig"}).

Finally, our study is, to our knowledge, the first attempt to provide indications about the embryonic origin of type I neurons. We found that all type I neurons were GFP labeled in Lhx6-Cre/R26R-YFP mice. As Lhx6 is a distinctive marker of the neurons originating from the MGE (Fogarty et al., [@B17]; Du et al., [@B13]), our results strongly suggest that type I neurons originate in this embryonic region. In agreement, we found that no type I nitrergic neurons expressed GFP in a 5-HT~3A~:GFP strain where fluorescence is found in neurons originating from the adjacent CGE and AEP/PO (Lee et al., [@B44]; Vucurovic et al., [@B65]). This finding is also in strong agreement with the notion that type I neurons constitute a subset of SOM-expressing GABAergic interneurons, since most originate in the MGE (Butt et al., [@B5]; Xu et al., [@B70]; Miyoshi et al., [@B46]; Wonders et al., [@B69]).

The features of type I interneurons appear well conserved across mammalian species (Yan and Garey, [@B72]; Franca et al., [@B18]). The morphology and the laminar distribution of type I neurons is consistent in rat (Gabbott and Bacon, [@B21]; Gabbott et al., [@B22]; Kubota et al., [@B41]), mouse (Lee and Jeon, [@B43]; present study), rabbit (Lee and Jeon, [@B43]), cat (Higo et al., [@B33]), monkey (Sandell, [@B53]; Smiley et al., [@B55]), and human (Judas et al., [@B35]). Similarly, SOM expression is a signature of type I nitrergic cells in rat (Vruwink et al., [@B64]; Kubota et al., [@B41]), monkey (Smiley et al., [@B55]), and human (Judas et al., [@B35]). Interestingly, type I nitrergic neurons also occur in substantial numbers in the subcortical white matter (Franca et al., [@B18]; Clancy et al., [@B9]). Thus, type I nitrergic neurons seem to be a ubiquitous and conserved feature of the mammalian cerebral cortex.

The consistent and comprehensive description of the properties of type I nitrergic cells provided in this study might prove useful to study the function of these neurons in the future. However, one should keep in mind that the features of type I neurons reported here might vary according to experimental conditions. Firstly, in rodents and primates, variations in neuronal density (Franca et al., [@B18]) and morphology (Freire et al., [@B19]) of type I neurons can occur between neocortical areas. Secondly, the features of type I neurons seem to be subjected to inter-species variations. For instance, type I cells do not express CB in rat (Gabbott et al., [@B22]) and human (Judas et al., [@B35]), while they express this marker in rabbit and mouse (Lee and Jeon, [@B43]; present study). More importantly, the modest expression of PV in type I cells which occurs in mouse (Lee and Jeon, [@B43]; present study) contrasts with data obtained in rat (Gabbott et al., [@B22]; Vruwink et al., [@B64]; Kubota et al., [@B41]), monkey (Smiley et al., [@B55]), and human (Judas et al., [@B35]) where type I cells only express SOM. This can give the impression that type I interneurons form two distinct classes in mouse. However, in our multiparametric analysis, the properties of PV expressing putative type I neurons were consistent with those of the other neurons of this cluster. Thus, we suggest that PV expression in mouse type I neurons is more likely to reflect intra-class variability. Further studies will be needed to explore whether variations in the properties of type I neurons translate functionally.

Type II interneurons represent a heterogeneous group of cells
-------------------------------------------------------------

Type II cells have initially been described in the neocortex of many mammalian species especially in primate and human neocortex (Aoki et al., [@B1]; Hashikawa et al., [@B31]; Yan et al., [@B73]). Although early studies failed to detect type II neurons in rodents (Gabbott and Bacon, [@B21]; Yan and Garey, [@B72]; Oermann et al., [@B48]) recent reports have evidenced that they were also present in these species (Freire et al., [@B20]; Lee and Jeon, [@B43]). Studies have illustrated the functional importance of this class in the modulation of the vascular tone (Cauli et al., [@B8]). However, because of the difficulties of visualizing type II interneurons, the characterization of these cells has been neglected.

In this study, we characterized type II cells in the somatosensory cortex of mouse. With double immunolabeling, we found that a significant proportion of these cells were immunoreactive either for PV, SOM, or VIP. PV has previously been observed in some faintly stained nNOS-expressing cells in rat (Kubota et al., [@B41]). However, to our knowledge this is the first report of expression of SOM and VIP in type II nitrergic interneurons. Interestingly, PV and SOM immunoreactive type II cells were preferentially aggregated in deep neocortical layers while VIP immunoreactive type II neurons accumulated in layer II/III. Since PV, SOM, and VIP reportedly never co-express in the cortex of mouse (Xu et al., [@B71]), and their expression did not sum to the total density of type II nitrergic cells, our data also indicated that a substantial part of type II neurons do not express either of these markers. Therefore, our immunological data strongly suggested that in the barrel cortex of mouse, type II interneurons corresponded to a heterogeneous population comprised of distinct subgroups exhibiting particular laminar preferences.

Agreeing with this hypothesis, our multiparametric analysis disclosed three groups of cells that putatively corresponded to type II cells. The laminar distributions and the expression of PV, SOM, and VIP mRNAs of these three clusters appeared in strong agreement with results obtained at the protein level for type II neurons. The most prominent group; Adapt-NPY (*n* = 19) populated all layers and corresponded to small, neurogliaform-like interneurons which did not express PV, SOM, or VIP. Our data are thus consistent with previous findings indicating that neurogliaform cells constitute the main subset of type II cells (Karagiannis et al., [@B36]; Kubota et al., [@B41]). Consistent with immunohistochemical data, the two other groups corresponded to non-adapting neurons accumulating in deep layers and expressing PV or SOM (non-Ad-PV/SOM; *n* = 9), and to adapting bipolar neurons expressing VIP and CR, which were preferentially found in layer II/III (Adapt-VIP/CR; *n* = 7).

The relevance of these three groups of type II neurons was further strengthened by our developmental study. Consistent with the known origin of VIP/CR neurons in the CGE (Butt et al., [@B5]; Lee et al., [@B44]; Vucurovic et al., [@B65]), our data indicate that type II cells preferentially express the CGE-AEP/PO specific marker 5-HT~3A~ in superficial layers. Conversely, in deep layers, type II neurons preferentially expressed Lhx6, consistent with the notion that PV and SOM-expressing neurons originate in the MGE (Butt et al., [@B5]; Xu et al., [@B70]; Miyoshi et al., [@B46]; Wonders et al., [@B69]). Finally, our data are consistent with the finding that neurogliaform cells can arise both in the MGE (Butt et al., [@B5]) and in the CGE (Lee et al., [@B44]; Vucurovic et al., [@B65]).

Thus, our study strongly suggests that type II neurons constitute a heterogeneous population of interneurons comprised of three classes: neurogliaforms expressing NPY, deep layers non-adapting cells expressing PV, or SOM and superficial bipolar cells expressing VIP/CR. Because of the consistency of our results, we are confident that the strategies employed here successfully disclosed the diversity of type II nitrergic interneurons in the neocortex of juvenile mouse. However, our data regarding type II interneurons display inconsistencies with data obtained in other cortical areas and animal models. Firstly, while we report that the densities of type I and type II cells are approximately equal in layer VI, another study performed in the visual cortex of mouse and rabbit found that type II cells were half as concentrated as type I cells in this layer (Lee and Jeon, [@B43]). Secondly, two previous studies performed in rat did not identify type II nitrergic interneurons expressing VIP or SOM at the histochemical level (Kubota et al., [@B41]) or in a similar multiparametric sample of interneurons (Karagiannis et al., [@B36]). Our finding regarding type II cells highlights further discrepancies with data obtained in primates. Indeed, we found that type II were about twofold more numerous than type I cells and populated all neocortical layers. By contrast, type II cells appeared about 20-fold more abundant than type I cells and exclusively located in supragranular layers in monkey (Yan et al., [@B73]; Yan and Garey, [@B72]; Smiley et al., [@B55]) and human (Judas et al., [@B35]). The molecular signature of type II cells also varies markedly in primates where they are characterized by the expression of CB but never express SOM or NPY (Smiley et al., [@B55]). Thus, this raises the intriguing possibility that type II cells might correspond to distinct cell types in different species.

Conclusion
==========

In the CNS, NO modulates a wealth of functions ranging from synaptic plasticity and neuronal excitability to blood perfusion (Garthwaite, [@B25]). Among the three isoforms of NO synthase, nNOS is specifically expressed in neurons and thus provides a specific substrate enabling NO signaling to integrate changes of neuronal activity (Zhou and Zhu, [@B74]). The present study provides a comprehensive characterization of the properties of nNOS-expressing neurons in the barrel cortex of juvenile mouse. Our results indicate that nNOS is expressed in several classes of interneurons. These groups are likely to be differentially recruited by oncoming signals underlying specific epochs of neocortical processing (Burkhalter, [@B4]). Thus, our study indicates that NO signaling is coupled, in a complex manner, to a wide array of processes performed in the neocortical network.
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